STADA

Press Releases

Press Releases

STADA: Nizhpharm acquisition successfully concluded

STADA Arzneimittel AG has successfully acquired  97.47% of the shares of the Russian pharmaceutical company Nizhpharm OJSC, Nizhny Novgorod, after the Russian anti-trust authorities approved the transaction and all contractual agreements had been implemented (see ad hoc release dated November 8, 2004 concerning the conclusion of the provisional agreement, published by DGAP, as well as ad hoc release dated December 22, 2004 concerning the conclusion of final agreements, published by DGAP).

Nizhpharm will be included in the scope of consolidation of the STADA Group as of January 1, 2005.

For more information, please contact:

STADA Arzneimittel AG
Corporate Communications
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506
e-mail: communications@stada.de

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Learn more

Sustainability

Sustainability

For STADA "All the best" means taking responsibility.

Learn more

entdecken